Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

This study is currently recruiting participants.

Verified by National Taiwan University Hospital, August 2004

First Received: September 12, 2005 No Changes Posted

Sponsor:	National Taiwan University Hospital
Information provided by:	National Taiwan University Hospital
ClinicalTrials.gov Identifier:	NCT00173316

Purpose

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Condition
Oral Cancer

Study Type:	Observational
Study Design:	Screening, Longitudinal, Defined Population, Retrospective Study
Official Title:	The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions

Resource links provided by NLM:

MedlinePlus related topics: Cancer Oral Cancer

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment:	80
Study Start Date:	August 2004
Estimated Study Completion Date:	June 2005

Detailed Description:

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Eligibility

Ages Eligible for Study:	18 Years to 85 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

oral cancer and oral precancer specimens

Exclusion Criteria:

other diseases

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00173316

Contacts

Contact: Chun-Pin Chiang, DMSc

886-2-23123456 ext 6855

cpchiang@ha.mc.ntu.edu.tw

Locations

Taiwan
National Taiwan university	Recruiting
Taipei, Taiwan, 100
Principal Investigator: Chun-Pin Chiang, DMSc

Sponsors and Collaborators

National Taiwan University Hospital

Investigators

Principal Investigator:

Chun-Pin Chiang, DMSc

National Taiwan University

More Information

No publications provided

Study ID Numbers:	9461700614
Study First Received:	September 12, 2005
Last Updated:	September 12, 2005
ClinicalTrials.gov Identifier:	NCT00173316 History of Changes
Health Authority:	Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:

vascular endothelial growth factor-C
VEGF-CR
lymphangiogenesis
host inflammatory responses

oral carcinogenesis
oral cancers
oral premalignant lesions

Additional relevant MeSH terms:

Mouth Diseases
Neoplasms
Neoplasms by Site
Growth Substances
Head and Neck Neoplasms
Physiological Effects of Drugs

Stomatognathic Diseases
Endothelial Growth Factors
Lip Diseases
Lip Neoplasms
Mouth Neoplasms
Pharmacologic Actions

ClinicalTrials.gov processed this record on February 08, 2010